Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-008299

Sorrento Therapeutics, Inc. · SRNE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Fan Yu
10% Owner
Bin Li
10% Owner
ABG SRNE Ltd
10% Owner
ABG II-SO Ltd
10% Owner
Period of report
Feb 6, 2018
Accepted (ET)
Feb 8, 2018 · 8:17 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000850261

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4,F6Feb 6, 2018S512,912$6.7541D1,478,529IThrough Ally Bridge LB Healthcare Master Fund Limited
Common StockF1,F2,F3,F4,F6Feb 7, 2018S150,000$7.1865D1,328,529IThrough Ally Bridge LB Healthcare Master Fund Limited
Common StockF1,F2,F3,F4,F5holding———1,310,588IThrough ABG II-SO Limited
Common StockF1,F2,F3,F4,F7holding———3,041,759IThrough ABG SRNE Limited
Common StockF1,F2,F3,F4,F8holding———1,408,027IThrough ABG Innovation-SO Limited

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
WarrantsF1,F2,F3,F4,F6,F9$8.50holding————May 31, 2019Common Stock432,432432,432I
WarrantsF1,F2,F3,F4,F7,F9$8.50holding————May 31, 2019Common Stock432,432432,432I
WarrantsF1,F2,F3,F4,F7,F10$8.50holding————Jun 7, 2019Common Stock540,540540,540I

Explanation of responses